We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Plant Health Care Plc | LSE:PHC | London | Ordinary Share | GB00B01JC540 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.15 | 4.32% | 3.62 | 3.30 | 4.00 | 3.62 | 3.44 | 3.56 | 675,665 | 16:28:44 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pesticides, Agric Chems, Nec | 11.77M | -9.48M | -0.0278 | -1.30 | 12.36M |
Date | Subject | Author | Discuss |
---|---|---|---|
26/4/2012 16:51 | Also in TYRATECH | fctwente | |
20/4/2012 15:29 | Fwiw ORA also had (July 2011) substantial holdings (>20%) in Nanoco, Obtala Resources, Tissue Regenix Grp, Oxford Advanced Surfaces, Oxford Pharmasciences Grp, and Antisoma. | bobdouthwaite | |
20/4/2012 14:20 | ORA up to 15% now | fctwente | |
18/4/2012 14:30 | DLEM, I didn't get the letter - what did it say? guess if you have the holding in a nominee account it doesn't get forwarded. | vega44 | |
18/4/2012 13:42 | I think the Chairman fell on his sword as two large shareholders were planning to vote against his reappointment. There have been some large buys since his announcement but no news on who led the coup. The February Finals suggested sales were growing so things may be looking up - at last! Is anyone going to the AGM? | bobdouthwaite | |
18/4/2012 12:08 | Has anyone any views on the untypical happenings at PHC? Unusual volumes over the past few months. ORA (Guernsey) Limited stake building. Letters from the company to shareholders to request support of AGM resolutions. Resignation of Chairman for personal reasons, days prior to the AGM. With the products reaching commercialisation, I would guess at a bid being imminent or perhaps ORA are planning to increase it's holding and/or influence. | dlem | |
05/4/2012 16:32 | Amazing this finished down on the day. | fctwente | |
28/2/2012 10:18 | interesting remarks from the Bayer Ceo today....."BAYER SEEKS ACQUISITIONS IN LIFE SCIENCES, HEALTH AND CROP SCIENCE"..... PHC fits the bill nicely.... | cool runnings | |
19/1/2012 09:16 | Encouraging trading update: The Board is pleased to report that the operating loss before share-based payments is expected to be approximately $6.7 million, on revenues of $7.9 million. Due to tight control over operating costs, the operating loss was better than expectations, with revenues being slightly less than expectations. As a consequence of the lower losses and strong collections from debtors, the Company is expecting to report cash and cash equivalents at year-end of US$14 million, significantly ahead of expectations. The Company is focused on accelerating the development and improving performance of its core Harpin and Myconate technologies. As a result, R&D spend on next generation product development and formulations doubled in 2011, and is expected to increase at a similar rate in 2012 to over $1mm. | fctwente | |
12/1/2012 17:39 | fctwente i agree your comments completely,having worked in tropical agribusiness for 30 years. all farmers are conservative and often reluctant to change. | cnx | |
12/1/2012 13:54 | cnx. In my opinion, farmers (particularly those in the corporate sense) require an exceptional case to be presented to them with regards to a roi. Which is why there is a lot of effort (and expense) directed towards trials. This is both costly and time consuming and small businesses like these are doomed to struggle with sales until such time as traction is achieved. I think that time to market is (in any profitable sense) usually badly underestimated. Either that, or this a known problem but not one that companies would like to bring to shareholders attention as it inevitably leads to a need for constant calls for cash. | fctwente | |
11/1/2012 20:02 | you are correct re syngenta. arysta has a marketing agreement and sales are ?"slow"?. but these two names implies near to "mainstream", but with what success? still agree your comments | cnx | |
11/1/2012 09:37 | cnx. My understanding is that Syngenta are trialling PIM products in Brazil. This is not the same as being an agent. Breaking in to the mainstream requires traction at distributor level. | fctwente | |
09/1/2012 18:55 | re above 331 PIM have syngenta and arysta as sales agents so should not have a problem entering "mainstream" PHC lost monsanto, i think but agree your comment in general | cnx | |
21/12/2011 09:22 | If sales are in line with forecasts then cash position is not an issue here. Reserves of $17m at end June. Even if they are below forecast there is enough cash for the foreseeable. This is underperforming due to a lack of sales traction. Similiar in many respects to Plant Impact. They are finding it tough breaking in to the mainstream. | fctwente | |
20/12/2011 13:23 | when does the cash run out ? | envirovision | |
20/12/2011 13:15 | And yet another new low - unless some strong sales news soon will either be taken over imo(if the products do what they say on the box) or continue to decline until taken private. Sorry to sound so gloomy at this time of year but having been following for years I am very concerned about any lack of traction - Very similar to many UK based "so called tech breakthrough companies" Edit at 13:15 Some gamble buying (12K) at 32p gone through since above written | pugugly | |
06/12/2011 17:09 | yes, here's hoping for some positive sales reports | cnx | |
28/11/2011 15:02 | any yet another new low and no real news of sales successes : ORA are usually very good at picking winners but in this case ????????? Views ? | pugugly | |
10/11/2011 16:40 | RNS : ORA Capital Partners Limited increased stake to from 5% to 10%. "The principal activity of ORA is the growth and development of businesses in which ORA has or acquires either a significant minority or a majority shareholding. ORA's holding generally results from participation in the formation of new businesses or from acquisitions. In selecting development opportunities, ORA focuses on sectors in which the Directors consider ORA to possess strengths through their collective experience, identifying specific opportunities that have the potential to meet the Company's return targets. While the current focus includes technology, financial services and resources (including renewable energy), ORA may develop businesses in other sectors if it identifies appropriate opportunities. The ORA team has significant experience in the creation, growth and management of businesses across the areas in which ORA operates, as well as a range of disciplines within capital markets." | dlem | |
09/11/2011 09:42 | I'm still holding some - and wishing I didn't! | bobdouthwaite | |
08/11/2011 19:57 | Yea I dont hold right now mind, you ? | envirovision | |
08/11/2011 16:25 | Now a 5 year low and below the floatation price - Anyone still following ? | pugugly |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions